ARV Facts
Facts about Antiretroviral Drugs
Find out more about
ARV damage to:
Protection against
ARV
organ damage
ARV damage to the heart
Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
Environ Mol Mutagen. 2007 Apr-May;48(3-4):190-200.
More
Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study.
HIV Med. 2008 Jun 16.
More
Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients.
Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):731-6. Epub 2003 Nov 11.
More
Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects.
Eur J Clin Microbiol Infect Dis. 2004 Aug;23(8):625-30. Epub 2004 Jul 28.
More
Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients.
Atherosclerosis. 2006 Jan;184(1):72-7.
More
Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3'-azido-3'-deoxythymidine.
Cardiovasc Toxicol. 2004;4(2):133-53.
More
